Epoprostanol,
Epoprostenol,
Epoprostenol Sodium,
Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,
Flolan,
Prostacyclin,
Prostaglandin I(2),
Prostaglandin I2,
Veletri,
Epoprostenol sodium,
Flolan,
Veletri,
Cyclo-Prostin,
UNII-4K04IQ1OF4,
Epoprostenol sodium [USAN:BAN],
61849-14-7,
EINECS 263-273-7,
U 53,217A,
4K04IQ1OF4,
prostacyclin,
U-53217A,
Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate,
Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate,
Sodium prostacyclin,
Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-,
NCGC00167427-01,
C20H31NaO5,
Floran,
Epoprostenolsodium,
Prostacyclin sodium,
ACT-385781A,
Prostaglandin X sodium,
Prostaglandin I2 sodium,
AC1O4BXH,
PROSTAGLANDIN I2 Na,
CHEMBL962,
DSSTox_CID_26617,
DSSTox_RID_81769,
DSSTox_GSID_46617,
SCHEMBL41344,
C20H31O5.Na,
BML1-F10,
DTXSID3046617,
LMHIPJMTZHDKEW-XQYLJSSYSA-M,
4UA76,
HMS1361K18,
HMS3648L14,
Tox21_112431,
AKOS024457370,
CAS-61849-14-7,
LS-176206,
U-53,217A,
V0155,
Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,
(5Z,13E,8R,9S,11R,12R,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt,
(5Z,9|A,11|A,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt,
sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate,
sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate,
epoprostenol,
prostaglandin I2,
Epoprosterol sodium,
Prostacyclin sodium salt,
C20H32O5.Na,
C20-H31-Na-O5,
CID5282410,
CID6364626,
2641S,
35121-78-9,